A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy
22265
Phase 1 other active
Quick answer
A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy for Coagulopathy, Sepsis is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Coagulopathy, Sepsis
- Phase
- Phase 1
- Modality
- other
- Status
- active